Below are 12 extreme FDA trades for 11 companies with market caps below $
200M which have pending new drug product decisions or other meetings/
milestones scheduled with the FDA that are expected to have a major impact
on each of the underlying stock prices as the PDUFA decision dates approach
and the decision is ultimately announced. A high risk/reward trading
approach to consider for speculative traders is investing a small amount of
money that you can afford to lose in a basket of stocks incl
